Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients

David R. Santiago-Dieppa, Jeffrey Steinberg, David Gonda, Vincent J. Cheung, Bob S. Carter, Clark C. Chen

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

Extracellular vesicles (EVs) are cell-secreted vesicles that range from 30-2000 nm in size. These vesicles are secreted by both normal and neoplastic cells. Physiologically, EVs serve multiple critical biologic functions, including cellular remodeling, intracellular communication, modulation of the tumor microenvironment and regulation of immune function. Because EVs contain genetic and proteomic contents that reflect the cell of origin, it is possible to detect tumor-specific material in EVs secreted by cancer cells. Importantly, EVs secreted by cancer cells transgress anatomic compartments and can be detected in the blood, cerebrospinal fluid, and other biofluids of cancer patients. In this context, there is a growing interest in analyzing EVs from the biofluid of cancer patients as a means of disease diagnosis and therapeutic monitoring. In this article, we review the development of EVs as a diagnostic platform for the most common form of brain cancer, glioblastoma, discuss potential clinical translational opportunities and identify the central challenges associated with future clinical applications.

Original languageEnglish (US)
Pages (from-to)819-825
Number of pages7
JournalExpert Review of Molecular Diagnostics
Volume14
Issue number7
DOIs
StatePublished - Jan 1 2014

Fingerprint

Glioblastoma
Biopsy
Neoplasms
Tumor Microenvironment
Extracellular Vesicles
Brain Neoplasms
Proteomics
Cerebrospinal Fluid
Communication

Keywords

  • biomarker
  • exosomes
  • extracellular vesicle
  • glioma
  • microvesicle

Cite this

Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients. / Santiago-Dieppa, David R.; Steinberg, Jeffrey; Gonda, David; Cheung, Vincent J.; Carter, Bob S.; Chen, Clark C.

In: Expert Review of Molecular Diagnostics, Vol. 14, No. 7, 01.01.2014, p. 819-825.

Research output: Contribution to journalReview article

Santiago-Dieppa, David R. ; Steinberg, Jeffrey ; Gonda, David ; Cheung, Vincent J. ; Carter, Bob S. ; Chen, Clark C. / Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients. In: Expert Review of Molecular Diagnostics. 2014 ; Vol. 14, No. 7. pp. 819-825.
@article{23867f2e3167431580b8b47b4066d2cc,
title = "Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients",
abstract = "Extracellular vesicles (EVs) are cell-secreted vesicles that range from 30-2000 nm in size. These vesicles are secreted by both normal and neoplastic cells. Physiologically, EVs serve multiple critical biologic functions, including cellular remodeling, intracellular communication, modulation of the tumor microenvironment and regulation of immune function. Because EVs contain genetic and proteomic contents that reflect the cell of origin, it is possible to detect tumor-specific material in EVs secreted by cancer cells. Importantly, EVs secreted by cancer cells transgress anatomic compartments and can be detected in the blood, cerebrospinal fluid, and other biofluids of cancer patients. In this context, there is a growing interest in analyzing EVs from the biofluid of cancer patients as a means of disease diagnosis and therapeutic monitoring. In this article, we review the development of EVs as a diagnostic platform for the most common form of brain cancer, glioblastoma, discuss potential clinical translational opportunities and identify the central challenges associated with future clinical applications.",
keywords = "biomarker, exosomes, extracellular vesicle, glioma, microvesicle",
author = "Santiago-Dieppa, {David R.} and Jeffrey Steinberg and David Gonda and Cheung, {Vincent J.} and Carter, {Bob S.} and Chen, {Clark C.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1586/14737159.2014.943193",
language = "English (US)",
volume = "14",
pages = "819--825",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients

AU - Santiago-Dieppa, David R.

AU - Steinberg, Jeffrey

AU - Gonda, David

AU - Cheung, Vincent J.

AU - Carter, Bob S.

AU - Chen, Clark C.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Extracellular vesicles (EVs) are cell-secreted vesicles that range from 30-2000 nm in size. These vesicles are secreted by both normal and neoplastic cells. Physiologically, EVs serve multiple critical biologic functions, including cellular remodeling, intracellular communication, modulation of the tumor microenvironment and regulation of immune function. Because EVs contain genetic and proteomic contents that reflect the cell of origin, it is possible to detect tumor-specific material in EVs secreted by cancer cells. Importantly, EVs secreted by cancer cells transgress anatomic compartments and can be detected in the blood, cerebrospinal fluid, and other biofluids of cancer patients. In this context, there is a growing interest in analyzing EVs from the biofluid of cancer patients as a means of disease diagnosis and therapeutic monitoring. In this article, we review the development of EVs as a diagnostic platform for the most common form of brain cancer, glioblastoma, discuss potential clinical translational opportunities and identify the central challenges associated with future clinical applications.

AB - Extracellular vesicles (EVs) are cell-secreted vesicles that range from 30-2000 nm in size. These vesicles are secreted by both normal and neoplastic cells. Physiologically, EVs serve multiple critical biologic functions, including cellular remodeling, intracellular communication, modulation of the tumor microenvironment and regulation of immune function. Because EVs contain genetic and proteomic contents that reflect the cell of origin, it is possible to detect tumor-specific material in EVs secreted by cancer cells. Importantly, EVs secreted by cancer cells transgress anatomic compartments and can be detected in the blood, cerebrospinal fluid, and other biofluids of cancer patients. In this context, there is a growing interest in analyzing EVs from the biofluid of cancer patients as a means of disease diagnosis and therapeutic monitoring. In this article, we review the development of EVs as a diagnostic platform for the most common form of brain cancer, glioblastoma, discuss potential clinical translational opportunities and identify the central challenges associated with future clinical applications.

KW - biomarker

KW - exosomes

KW - extracellular vesicle

KW - glioma

KW - microvesicle

UR - http://www.scopus.com/inward/record.url?scp=84906306079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906306079&partnerID=8YFLogxK

U2 - 10.1586/14737159.2014.943193

DO - 10.1586/14737159.2014.943193

M3 - Review article

VL - 14

SP - 819

EP - 825

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 7

ER -